Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Yeda
15.07.2026
Brain & Behavior, Immunology, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Benefiting Humanity, Diagnostic Techniques and Drugs
Phase 1 trial reports positive results for a brain-protective immunotherapy in early Alzheimer's disease.
31.10.2022
Technology & Applications, Yeda Technology Transfer, Benefiting Humanity, Biotechnology, Diagnostic Techniques and Drugs
Equipped with a team of industry experts, innovation hub Bina invites Weizmann Institute scientists to examine the applicative potential of...
28.11.2021
Structural Biology, Cancer, Molecular and Cell Biology, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Diagnostic Techniques and Drugs
A particularly “sticky” molecule could lead to the development of an effective treatment for cancer
23.02.2015
The discovery of a new breast cancer gene holds hope for treatment
21.10.2014
Combining two technologies makes a drug compound stronger and longer-lasting
19.05.2013
Yeda Research and Development Company, Ltd., was established in 1959 to...
25.07.2012
Yeda, the technology transfer arm of the Weizmann...
07.06.2012
An Australian company will develop the technology to reduce coal emissions
19.03.2012
A synthetic molecule causes a useful immune response in mice
19.03.2012
The new method could put an end to fuzzy, cropped thumbnail images
